Lai Kai Pharmaceutical-B (02105): Xie Ling and Zhou Jian were appointed as members of the Nomination and Corporate Governance Committee

Zhitong Finance App News, Lai Kai Pharmaceutical-B (02105) announced that since December 12, 2025, executive director Ms. Xie Ling and independent non-executive director Mr. Zhou Jian have been appointed as members of the Company's Nomination and Corporate Governance Committee.